Your browser doesn't support javascript.
loading
Cocaine-induced changes in CX3CL1 and inflammatory signaling pathways in the hippocampus: Association with IL1ß.
Montesinos, Jorge; Castilla-Ortega, Estela; Sánchez-Marín, Laura; Montagud-Romero, Sandra; Araos, Pedro; Pedraz, María; Porras-Perales, Óscar; García-Marchena, Nuria; Serrano, Antonia; Suárez, Juan; Baixeras, Elena; Rodríguez-Arias, Marta; Santín, Luis J; Miñarro, José; Guerri, Consuelo; Rodríguez de Fonseca, Fernando; Pavón, Francisco Javier.
Afiliação
  • Montesinos J; Department of Molecular and Cellular Pathology of Alcohol, Príncipe Felipe Research Center, Valencia, 46012, Spain; Department of Neurology, Columbia University Medical Center, New York, 10032, USA.
  • Castilla-Ortega E; Unidad de Gestión Clínica (UGC) de Salud Mental, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, 29010, Spain.
  • Sánchez-Marín L; Unidad de Gestión Clínica (UGC) de Salud Mental, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, 29010, Spain.
  • Montagud-Romero S; Department of Psychobiology, Facultad de Psicología, Universitat de València, Valencia, 46010, Spain.
  • Araos P; Unidad de Gestión Clínica (UGC) de Salud Mental, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, 29010, Spain; Departamento de Psicobiología y Metodología de las Ciencias del Comportamiento, Facultad de Psicología, Uni
  • Pedraz M; Unidad de Gestión Clínica (UGC) de Salud Mental, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, 29010, Spain.
  • Porras-Perales Ó; Unidad de Gestión Clínica (UGC) de Salud Mental, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, 29010, Spain; UGC del Corazón. Instituto IBIMA, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, Mála
  • García-Marchena N; Unidad de Gestión Clínica (UGC) de Salud Mental, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, 29010, Spain.
  • Serrano A; Unidad de Gestión Clínica (UGC) de Salud Mental, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, 29010, Spain.
  • Suárez J; Unidad de Gestión Clínica (UGC) de Salud Mental, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, 29010, Spain.
  • Baixeras E; Unidad de Gestión Clínica (UGC) de Salud Mental, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, 29010, Spain.
  • Rodríguez-Arias M; Department of Psychobiology, Facultad de Psicología, Universitat de València, Valencia, 46010, Spain.
  • Santín LJ; Departamento de Psicobiología y Metodología de las Ciencias del Comportamiento, Facultad de Psicología, Universidad de Málaga, Málaga, 29071, Spain.
  • Miñarro J; Department of Psychobiology, Facultad de Psicología, Universitat de València, Valencia, 46010, Spain.
  • Guerri C; Department of Molecular and Cellular Pathology of Alcohol, Príncipe Felipe Research Center, Valencia, 46012, Spain.
  • Rodríguez de Fonseca F; Unidad de Gestión Clínica (UGC) de Salud Mental, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, 29010, Spain. Electronic address: fernando.rodriguez@ibima.eu.
  • Pavón FJ; Unidad de Gestión Clínica (UGC) de Salud Mental, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga, Universidad de Málaga, Málaga, 29010, Spain. Electronic address: javier.pavon@ibima.eu.
Neuropharmacology ; 162: 107840, 2020 01 01.
Article em En | MEDLINE | ID: mdl-31704270
ABSTRACT
Cocaine induces neuroinflammatory response and interleukin-1 beta (IL1ß) is suggested a final effector for many cocaine-induced inflammatory signals. Recently, the chemokine fractalkine (CX3CL1) has been reported to regulate hippocampus-dependent neuroinflammation and synaptic plasticity via CX3C-receptor 1 (CX3CR1), but little is known about the impact of cocaine. This study is mainly focused on the characterization of CX3CL1, IL1ß and relevant inflammatory signal transduction pathways in the hippocampus in acute and repeated cocaine-treated male mice. Complementarily, the rewarding properties of cocaine were also assessed in Cx3cr1-knockout (KO) mice using a conditioned place preference (CPP). We observed significant increases in CX3CL1 and IL1ß concentrations after cocaine, although repeated cocaine produced an enhancement of CX3CL1 concentrations. CX3CL1 and IL1ß concentrations were positively correlated in acute (r = +0.61) and repeated (r = +0.82) cocaine-treated mice. Inflammatory signal transduction pathways were assessed. Whereas acute cocaine-treated mice showed transient increases in p-ERK1/2/ERK1/2 and p-p65/p65 NFκB ratios after cocaine injection, repeated cocaine-treated mice showed transient increases in p-ERK1/2/ERK1/2, p-p38/p38 MAPK, p-NFκB p65/NF-κB p65 and p-CREB/CREB ratios. Baseline p-p38/p38 MAPK and p-CREB/CREB ratios were downregulated in repeated cocaine-treated mice. Regarding the cocaine-induced CPP, Cx3cr1-KO mice showed a notably impaired extinction but no differences during acquisition and reinstatement. These results indicate that cocaine induces alterations in CX3CL1 concentrations, which are associated with IL1ß concentrations, and activates convergent inflammatory pathways in the hippocampus. Furthermore, the CX3CL1/CX3CR1 signaling could mediate the processes involved in the extinction of cocaine-induced CPP.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cocaína / Inibidores da Captação de Dopamina / Interleucina-1beta / Quimiocina CX3CL1 / Hipocampo / Inflamação Tipo de estudo: Risk_factors_studies Limite: Animals Idioma: En Revista: Neuropharmacology Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cocaína / Inibidores da Captação de Dopamina / Interleucina-1beta / Quimiocina CX3CL1 / Hipocampo / Inflamação Tipo de estudo: Risk_factors_studies Limite: Animals Idioma: En Revista: Neuropharmacology Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos